Key result
Omics technologies offer robust discovery of novel antigens and biomarkers for acute infectious gastroenteritis, potentially improving diagnosis, prognosis, and case management.
Why the study?
Acute infectious gastroenteritis remains a leading cause of childhood mortality with shifting pathogens, warranting review of omics technologies to discover biomarkers for pathogen detection, prognosis, and management.
Omics technologies offer a promising approach for discovering novel biomarkers to improve the diagnosis, management, and outbreak detection of acute infectious gastroenteritis.
Answers are grounded in this paper and cite their sources.
Should not yet change clinical practice in pediatric gastroenteritis; leaves open prospective validation of omics biomarkers.
Acute infectious gastroenteritis (AGE) is among the leading causes of mortality in children less than 5 years of age worldwide. There are many causative agents that lead to this infection, with rotavirus being the commonest pathogen in the past decade. However, this trend is now being progressively replaced by another agent, which is the norovirus. Apart from the viruses, bacteria such as Salmonella and Escherichia coli and parasites such as Entamoeba histolytica also contribute to AGE. These agents can be recognised by their respective biological markers, which are mainly the specific antigens or genes to determine the causative pathogen. In conjunction to that, omics technologies are currently providing crucial insights into the diagnosis of acute infectious gastroenteritis at the molecular level. Recent advancement in omics technologies could be an important tool to further elucidate the potential causative agents for AGE. This review will explore the current available biomarkers and antigens available for the diagnosis and management of the different causative agents of AGE. Despite the high-priced multi-omics approaches, the idea for utilization of these technologies is to allow more robust discovery of novel antigens and biomarkers related to management AGE, which eventually can be developed using easier and cheaper detection methods for future clinical setting. Thus, prediction of prognosis, virulence and drug susceptibility for active infections can be obtained. Case management, risk prediction for hospital-acquired infections, outbreak detection, and antimicrobial accountability are aimed for further improvement by integrating these capabilities into a new clinical workflow.
No takes yet. Share an insight, caveat, or question.
Hasan et al. (2021) conducted a review in Acute infectious gastroenteritis. Omics technologies and biomarkers was evaluated. Omics technologies offer robust discovery of novel antigens and biomarkers for acute infectious gastroenteritis, potentially improving diagnosis, prognosis, and case management.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: